NCT00358683View on ClinicalTrials.gov

A Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohn's Disease

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2007

Conditions
Crohn's Disease
Interventions
DRUG

Certolizumab pegol

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
lead

UCB Pharma

INDUSTRY